135 related articles for article (PubMed ID: 6362203)
21. Comparative efficacy of halcinonide and fluocinonide creams in psoriasis and eszematous dermatoses.
Sudilovsky A; Clewe TH
J Clin Pharmacol; 1975; 15(11-12):779-84. PubMed ID: 1104668
[TBL] [Abstract][Full Text] [Related]
22. Multicenter trial analysis. Fluocinonide and betamethasone gel in psoriasis.
Barsky S
Arch Dermatol; 1976 Dec; 112(12):1729-33. PubMed ID: 795379
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of once-daily treatment regimens with calcipotriol/betamethasone dipropionate ointment and calcipotriol ointment in psoriasis vulgaris.
Kragballe K; Noerrelund KL; Lui H; Ortonne JP; Wozel G; Uurasmaa T; Fleming C; Estebaranz JL; Hanssen LI; Persson LM
Br J Dermatol; 2004 Jun; 150(6):1167-73. PubMed ID: 15214905
[TBL] [Abstract][Full Text] [Related]
24. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: quality-of-life outcomes of a randomized controlled trial of supervised treatment of psoriasis in a day-care setting.
de Korte J; van der Valk PG; Sprangers MA; Damstra RJ; Kunkeler AC; Lijnen RL; Oranje AP; de Rie MA; de Waard-van der Spek FB; Hol CW; van de Kerkhof PC
Br J Dermatol; 2008 Feb; 158(2):375-81. PubMed ID: 18067483
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and safety of topical calcitriol 3 microg/g ointment, a new topical therapy for chronic plaque psoriasis.
Kircik L
J Drugs Dermatol; 2009 Aug; 8(8 Suppl):s9-16. PubMed ID: 19702031
[TBL] [Abstract][Full Text] [Related]
26. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: a randomized controlled trial of supervised treatment of psoriasis vulgaris in a day-care setting.
van de Kerkhof PC; van der Valk PG; Swinkels OQ; Kucharekova M; de Rie MA; de Vries HJ; Damstra R; Oranje AP; de Waard-van der Spek FB; van Neer P; Lijnen RL; Kunkeler AC; van Hees C; Haertlein NG; Hol CW
Br J Dermatol; 2006 Oct; 155(4):800-7. PubMed ID: 16965431
[TBL] [Abstract][Full Text] [Related]
27. Treatment of psoriasis with topically applied tretinoin and steroid ointment.
Kaidbey KH; Petrozzi JW; Kligman AM
Arch Dermatol; 1975 Aug; 111(8):1001-3. PubMed ID: 786170
[TBL] [Abstract][Full Text] [Related]
28. Adrenal suppression with high-potency corticosteroid ointment formulations in normal subjects.
Novak E; Francom SF; Schlagel CA
Clin Ther; 1983; 6(1):59-71. PubMed ID: 6370438
[TBL] [Abstract][Full Text] [Related]
29. The effect of topical fluocinonide ointment on phototherapy of psoriasis.
LeVine MJ; Parrish JA
J Invest Dermatol; 1982 Feb; 78(2):157-9. PubMed ID: 7057051
[TBL] [Abstract][Full Text] [Related]
30. [Interval treatment with local corticosteroids and bases].
Schmid P
Fortschr Med; 1981 Jul; 99(27-28):1102-4. PubMed ID: 7262795
[TBL] [Abstract][Full Text] [Related]
31. Tachyphylaxis to the action of topically applied corticosteroids.
du Vivier A; Stoughton RB
Arch Dermatol; 1975 May; 111(5):581-3. PubMed ID: 1130802
[TBL] [Abstract][Full Text] [Related]
32. Fluocinolone acetonide topical oil for scalp psoriasis.
Pauporte M; Maibach H; Lowe N; Pugliese M; Friedman DJ; Mendelsohn H; Cargill I; Ramirez R
J Dermatolog Treat; 2004 Dec; 15(6):360-4. PubMed ID: 15764047
[TBL] [Abstract][Full Text] [Related]
33. [A double-blind clinical trial of fluocinonide and betamethasone valerate in psoriasis].
Feuerman E
Harefuah; 1974 Jul; 87(2):59-60. PubMed ID: 4605470
[No Abstract] [Full Text] [Related]
34. Clinical assessment of patients with recalcitrant psoriasis in a randomized, observer-blind, vehicle-controlled trial using indigo naturalis.
Lin YK; Chang CJ; Chang YC; Wong WR; Chang SC; Pang JH
Arch Dermatol; 2008 Nov; 144(11):1457-64. PubMed ID: 19015420
[TBL] [Abstract][Full Text] [Related]
35. [Low-dose dithranol in psoriasis of the face].
Heller G
Dermatol Monatsschr; 1989; 175(1):35-9. PubMed ID: 2646159
[TBL] [Abstract][Full Text] [Related]
36. The efficacy of three class I topical synthetic corticosteroids, fluocinonide 0.1% cream, clobetasol 0.05% cream and halobetasol 0.05% cream: a Scholtz-Dumas bioassay comparison.
Lee CS; Koo J
J Drugs Dermatol; 2009 Aug; 8(8):751-5. PubMed ID: 19663113
[TBL] [Abstract][Full Text] [Related]
37. Fluocinonide: a new topical corticosteroid for psoriasis and other dermatoses.
Counce JH; Brass A
J La State Med Soc; 1972 Oct; 124(10):365-7. PubMed ID: 5079531
[No Abstract] [Full Text] [Related]
38. Clinical comparison of desonide cream with fluocinonide cream in steroid-responsive dermatologic disorders.
Barsky S
Cutis; 1976 Dec; 18(6):826-30. PubMed ID: 797554
[TBL] [Abstract][Full Text] [Related]
39. Discoid lupus erythematosus. Diagnostic features and evaluation of topical corticosteroid therapy.
Roenigk HH; Martin JS; Eichorn P; Gilliam JN
Cutis; 1980 Mar; 25(3):281-5. PubMed ID: 6987043
[No Abstract] [Full Text] [Related]
40. Intrinsic potencies of novel thiol ester corticosteroids RS-85095 and RS-21314 as compared with clobetasol 17-propionate and fluocinonide.
Ong JT; Poulsen BJ; Akers WA; Scholtz JR; Genter FC; Kertesz DJ
Arch Dermatol; 1989 Dec; 125(12):1662-5. PubMed ID: 2589861
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
